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Sir,
It is reassuring that Dr Ingleby reaches the same conclusion as
we did, that black patients have earlier onset on average than white
patients, even after taking into account the different age
distributions of the populations. Unlike Dr Ingleby, we are
reluctant to attempt to deduce absolute incidence from our
figures, as hospital admissions do not exactly correspond to
geographical areas. Therefore, we cannot be certain that the
differences are entirely because of the ‘black other’ subgroup, as
suggested by Dr Ingleby. Although the ‘black other’ category has
the youngest age at onset in our data, the black African, Caribbean
and British patients were also significantly younger than white
patients (Po0.001). The poorer survival in tumours 2cm in size or
less was also observed in all the black ethnic subgroups.
Dr Ingleby queries the effect of socioeconomic status. As
measured by the Index of Multiple Deprivation, this did not differ
significantly between ethnic groups, nor did it have a significant
effect on survival.
We have taken care to avoid knee-jerk reactions, such as to
recommend an early detection response to these observations. The
fact that the poorer survival of black patients was confined to small
tumours suggests that early detection approaches are not the
solution, or at least not the whole solution. Our next task is the
further study of aetiology and tumour biology to find out why
there is earlier onset among black patients and why they have
poorer survival in the case of small tumours. When these questions
have been answered, we will be in a better position to prescribe
appropriate control measures.
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